Hollywood, CA, United States of America

Desmond Barry Keenan

This inventor holds 39 USPTO granted patents and 6 published patent applications, plus 13 CIPO patents and 15 EPO patents, primarily in Closed-Loop Infusion Systems. Top assignees: Medtronic Minimed, Inc., Adidas Ag, Vivometrics, Inc.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Desmond Barry Keenan. Retrieved from https://idiyas.com/inventor/desmond-barry-keenan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 39 

% Patents Active = 97.4

 

 

Average Co-Inventor Count = 3.5

ph-index = 12

Forward Citations = 1,822(Granted Patents)


Location History:

  • Sherman Oaks, CA (US) (2010 - 2014)
  • Santa Barbara, CA (US) (2007 - 2016)
  • Los Angeles, CA (US) (2016)
  • Valencia, CA (US) (2019 - 2022)
  • Hollywood, CA (US) (2016 - 2024)

Company Filing History:


Years Active: 2007-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Infusion Devices
Glucose Calibration
Medical Device Updates
Closed-Loop Control
Glycemic Response
Patient Monitoring
Sensor Redundancy
Physiological Sensors
Notifications Systems
Control Information
Insulin Compensation
Data Processing
39 patents (USPTO):Explore Patents

Title: Desmond Barry Keenan: Innovator in Medical Devices

Introduction

Desmond Barry Keenan, based in Hollywood, CA, is a renowned inventor who has made significant contributions to the field of medical technology. With an impressive portfolio of 37 patents, Keenan has developed innovative solutions that enhance the functionality and efficiency of medical devices, particularly in infusion systems. His work demonstrates a commitment to improving patient care through advanced technology.

Latest Patents

Keenan's latest patents include groundbreaking advancements in extensible infusion devices. His innovation encompasses infusion systems, devices, and related operating methods that enhance the use of various fluid types for patient treatment. One exemplary method involves the automatic identification of fluid types, allowing for tailored delivery based on the pharmacokinetic characteristics of the fluid. This ensures that the infusion device updates control parameters in real time, optimizing the treatment process for users.

Another notable patent focuses on the streamed communication of updated control information between medical devices and intermediate devices. This system allows for the collection of measurement data related to a user's condition and the dynamic adjustment of the medical device based on this data, thereby promoting adaptive treatment regimes.

Career Highlights

Throughout his career, Desmond Barry Keenan has been affiliated with leading companies in the medical technology industry. He has notably worked with Medtronic Minimed, Inc., where he contributed to advancements in diabetes care technology. Keenan also lent his expertise to Adidas AG, demonstrating versatility in his innovative approach across different sectors.

Collaborations

Keenan’s work has been shaped by collaborations with skilled professionals such as John Joseph Mastrototaro and Benyamin Grosman. Their shared expertise has propelled the development of transformative medical devices, combining efforts to enhance patient treatment mechanisms.

Conclusion

Desmond Barry Keenan's contributions to the medical device industry through his patented inventions reflect a deep understanding of technology and patient needs. His innovative work in infusion devices and medical communication systems positions him as a leading figure in healthcare advancements. As he continues to drive innovation, the healthcare industry can expect further enhancements that prioritize patient safety and treatment efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…